Insider holders · CIK 0002023658
Bicara Therapeutics Inc. · BCAX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Claire MazumdarChief Executive Officer | 362,152 | — | 362,152 | Aug 12, 2026 · 4:19 pm EDT | Form 4 |
| Ryan CohlheppPresident, COO & Interim CEO | 181,641 | — | 181,641 | Sep 10, 2026 · 4:23 pm EDT | Form 4 |
| Ivan HyepChief Financial Officer | 129,855 | — | 129,855 | Aug 12, 2026 · 4:19 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.